ResultsIQ

ResultsIQ › Latest results › Natural Capsules Limited

Natural Capsules Limited Q2 FY26 results deck summary

NSE: NATCAPSUQ · BSE: 524654

Results deck of 14 Nov 2025, summarised by AI from the filing.

Q2FY26 revenue ₹45.80 cr (+11.11% Y-o-Y) but EBITDA (₹0.88 cr) and PAT (₹6.99 cr) as US tariffs hit HPMC expansion.

Key takeaways

  1. Guidance Management expects to commission the new production line by the end of this quarter and remains on track with its capital expenditure plan.
  2. Change EBITDA turned negative at (₹0.88 cr) in Q2FY26 from ₹0.32 cr in Q1FY26, a (377.07%) Q-o-Q decline.
  3. Driver Growth in the capsules segment is expected to pick up once there is more clarity on the US tariffs.
  4. Risk US tariffs on Indian exports hit demand in the US market, affecting the HPMC capacity expansion growth triggers.

Original filing on BSE

Natural Capsules Limited Q1 FY27 results

As filed: Revenue ₹48.7 cr (+8% year on year), EBITDA ₹1.1 cr (+12% year on year), PAT −₹5.7 cr, EBITDA margin 2.3% (+8 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹58.5 cr (+30% year on year), EBITDA ₹1.3 cr (−73% year on year), PAT −₹5.0 cr (−300% year on year), EBITDA margin 2.3% (−884 bps). Score 20 of 100, Below trend. EBITDA margin fell 884 bps year on year. Consolidated profit -598% but standalone +84%. Not enough history for a trend yet: scored on growth alone. Share price after the results: −6.5% in 29 days (Nifty 500: +0.6%).
  • Q3 FY26: Revenue ₹34.2 cr, EBITDA ₹1.9 cr, PAT ₹0.4 cr, EBITDA margin 5.5%. Not scored. No result for the same quarter last year. Share price after the results: −10.5% in 28 days (Nifty 500: −8.2%).
  • Q2 FY26: Revenue ₹45.0 cr, EBITDA ₹5.0 cr, PAT ₹3.0 cr, EBITDA margin 11.1%. Not scored. No result for the same quarter last year. Share price after the results: −11.6% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹44.0 cr, EBITDA ₹4.0 cr, PAT ₹3.0 cr, EBITDA margin 9.1%. Not scored. No result for the same quarter last year. Share price after the results: −7.2% in 30 days (Nifty 500: 0.0%).
  • Q4 FY25: Revenue ₹44.0 cr, EBITDA ₹5.0 cr, PAT ₹3.0 cr, EBITDA margin 11.4%. Not scored. No result for the same quarter last year. Share price after the results: −2.2% in 29 days (Nifty 500: +3.3%).

Past price moves after results do not indicate future moves. Not a recommendation.

Natural Capsules Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.